Pyxis Oncology (PYXS) Return on Equity [ROE] (2021 - 2026)
Pyxis Oncology (PYXS) reported Return on Equity [ROE] of -258.52% for Q2 2026, down 154.76 percentage points from -103.77% a year earlier.
Powered by 
Analysis
Pyxis Oncology (PYXS) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Pyxis Oncology posted Return on Equity [ROE] of -91.45%, down 28.70 percentage points from FY2024.
- Return on Equity [ROE] has a four-year change of -34.71 percentage points (FY2021 to FY2025).
- By year, Return on Equity [ROE] came in at -62.75% in FY2024 (-11.18 pp), -51.58% in FY2023 (+5.62 pp), -57.19% in FY2022 (-0.45 pp) and -56.74% in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2021.
- Year over year, Return on Equity [ROE] gained in 1 of the last seven quarters, with an average year-over-year change of -58.08 percentage points.
- The high point for year-over-year Return on Equity [ROE] in five years was Q2 2024 (a gain of 32.38 percentage points); the low point was Q2 2026 (a drop of 154.76 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.97% |
| 10 | Pyxis Oncology | 112.79 Mn | -152.27 Mn | - | -258.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -258.52% |
| Dec 31, 2025 | -131.19% |
| Sep 30, 2025 | -127.56% |
| Jun 30, 2025 | -103.77% |
| Mar 31, 2025 | -87.48% |
| Dec 31, 2024 | -58.48% |
| Sep 30, 2024 | -36.28% |
| Jun 30, 2024 | -34.54% |
| Mar 31, 2024 | -38.91% |
| Dec 31, 2023 | -57.32% |
| Sep 30, 2023 | -67.43% |
| Jun 30, 2023 | -66.92% |
| Mar 31, 2023 | -69.41% |
| Dec 31, 2022 | -69.07% |
| Sep 30, 2022 | -50.43% |
| Jun 30, 2022 | -38.15% |
| Mar 31, 2022 | -26.41% |
| Dec 31, 2021 | -73.41% |
API Access
Pyxis Oncology Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PYXS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PYXS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PYXS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();